Top global biotech companies selection based on market cap 2021
This statistic depicts a selection of global top biotechnology companies based on market capitalization as of October 4, 2021. At this point, Danish biopharmaceutical manufacturer Novo Nordisk was ranked second among such companies, with a market capitalization of around 170 billion U.S. dollars.
Global biotechnology
AbbVie and Novo Nordisk are among the largest mostly biotech-oriented companies in the world. In October 2021, AbbVie, a company based in the U.S., had a market capitalization of 193 billion U.S. dollars, while Novo Nordisk had market capitalization of nearly 170 billion U.S. dollars. As of 2018, there were 1,171 companies in the United States dedicated to biotechnology, while, in comparison, Germany had 679 companies. Biotech companies located in the San Francisco Area and in Los Angeles/Orange County generate the highest amount of biotech revenue within the United States.
In the United States, medical biotechnology is a significant component of the whole biotech industry. Jobs in research, testing, and medical laboratories have increased significantly. Humira, an anti-inflamatory drug, was developed by AbbVie and has generated over 20 billion U.S. dollars in revenue globally in 2020. The biopharmaceutical market is expected to continue to grow due to new innovations and the demand for quality medical technologies. Biotechnology is also commonly used in agriculture. Biotech crops in the United States accounts for more than half of the world’s total. With a total of 90.8 million acres of corn crops in the United States, only 7.3 million acres are considered non-biotech fields. Biotechnology also extends into the industrial sector, providing innovation for nanotechnology, enzymes, and biofuels.
Global biotechnology
AbbVie and Novo Nordisk are among the largest mostly biotech-oriented companies in the world. In October 2021, AbbVie, a company based in the U.S., had a market capitalization of 193 billion U.S. dollars, while Novo Nordisk had market capitalization of nearly 170 billion U.S. dollars. As of 2018, there were 1,171 companies in the United States dedicated to biotechnology, while, in comparison, Germany had 679 companies. Biotech companies located in the San Francisco Area and in Los Angeles/Orange County generate the highest amount of biotech revenue within the United States.
In the United States, medical biotechnology is a significant component of the whole biotech industry. Jobs in research, testing, and medical laboratories have increased significantly. Humira, an anti-inflamatory drug, was developed by AbbVie and has generated over 20 billion U.S. dollars in revenue globally in 2020. The biopharmaceutical market is expected to continue to grow due to new innovations and the demand for quality medical technologies. Biotechnology is also commonly used in agriculture. Biotech crops in the United States accounts for more than half of the world’s total. With a total of 90.8 million acres of corn crops in the United States, only 7.3 million acres are considered non-biotech fields. Biotechnology also extends into the industrial sector, providing innovation for nanotechnology, enzymes, and biofuels.
